Identification of unique neoantigen qualities in long-term survivors of pancreatic cancerSteven D. Leach, Marc A. Attiyeh, Benjamin D. Medina et al.|Nature|2017Cited by 1.2k
Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisHarlan F. Weisman, Douglas T. Fearon, Michelle K. Leppo et al.|Science|1990Cited by 979
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Enrico Lugli, Guido Kroemer et al.|Oncotarget|2014Cited by 469
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemiaEdward W. Roberts, Douglas T. Fearon|The Journal of Experimental Medicine|2013Cited by 406
T cell–Mediated Development of Stromal Fibroblasts with an Immune-Enhancing Chemokine ProfileRan Yan, Douglas T. Fearon|Cancer Immunology Research|2023Cited by 18